Pacira BioSciences Inc.

24.07
-0.78 (-3.14%)
At close: Apr 01, 2025, 3:59 PM
23.38
-2.85%
After-hours: Apr 01, 2025, 04:26 PM EDT

Pacira BioSciences Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue 700.97M 674.98M 666.82M 541.53M 420.83M
Cost of Revenue n/a 184.67M 199.29M 140.25M 117.33M
Gross Profit 700.97M 490.31M 467.53M 401.28M 303.5M
Operating Income -73.37M 87.67M 60.02M 131.06M 46.35M
Interest Income 19.69M 11.44M 4.54M 896K 4.63M
Pretax Income -63.11M 61.7M 13.3M 56.4M 20.09M
Net Income -99.56M 41.95M 15.91M 41.98M 145.52M
Selling & General & Admin 294.1M 269.44M 254.52M 199.34M 193.52M
Research & Development 81.58M 76.26M 84.8M 55.55M 59.42M
Other Expenses 398.66M 56.94M 57.29M 13.55M 7.87M
Operating Expenses 774.34M 402.63M 396.6M 268.44M 260.8M
Interest Expense 13.44M 20.31M 39.98M 31.75M 25.67M
Selling & Marketing Expenses 172.01M 153.04M 145M 111.02M 118.68M
Cost & Expenses 774.34M 587.3M 595.9M 408.7M 378.13M
Income Tax 36.45M 19.75M -2.61M 14.42M -125.43M
Shares Outstanding (Basic) 46.24M 46.22M 45.52M 44.26M 42.67M
Shares Outstanding (Diluted) 46.24M 51.98M 46.54M 45.63M 43.68M
EPS (Basic) -2.15 0.91 0.35 0.95 3.41
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA 29.12M 157.58M 144.78M 118.47M 71.42M
Depreciation & Amortization 78.78M 75.57M 91.5M 28.55M 19.91M